A urine-based genomic assay improves risk stratification for patients with high-risk hematuria stratified according to the American Urological Association guidelinesJ. de Jong, O. Pijpers, K. van Kessel, J. Boormans, W. Van Criekinge, E. Zwarthoff and Y. Lotan (2023) EUROPEAN UROLOGY ONCOLOGY, 6,
Challenges in neoantigen-directed therapeuticsL. Lybaert, S. Lefever, B. Fant, E. Smits, B. De Geest, K. Breckpot, L. Dirix, S. Feldman, W. Van Criekinge, K. Thielemans, S. van der Burg, P. Ott and C. Bogaert (2023) CANCER CELL, 41,
Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosisT. Govers, M. Resnick, A. Rastinehad, L. Caba, J. Groskopf and W. Van Criekinge (2023) WORLD JOURNAL OF UROLOGY, 41,
HIV-PULSE : a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterizationL. Lambrechts, N. Bonine, R. Verstraeten, M. Pardons, Y. Noppe, S. Rutsaert, F. Van Nieuwerburgh, W. Van Criekinge, B. Cole and L. Vandekerckhove (2023) NUCLEIC ACIDS RESEARCH, 51,